{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:01:51Z","timestamp":1790740911712,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.exer.2026.111118","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:30:20Z","timestamp":1781245820000},"page":"111118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasma homocysteine and Endothelin-1 dysregulation: Insights into retinal endothelial dysfunction"],"prefix":"10.1016","volume":"270","author":[{"given":"Mohamed","family":"MSA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.exer.2026.111118_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.exer.2026.111118_bib2","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000144462.08345.B9","article-title":"Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction","volume":"110","author":"Amiri","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamaophthalmol.2015.4070","article-title":"Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular dema: a systematic review and meta-analysis","volume":"134","author":"Avery","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0002-9394(03)00864-X","article-title":"Association of neovascular age-related macular degeneration and hyperhomocysteinemia","volume":"137","author":"Axer-Siegel","year":"2004","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/life13051098","article-title":"Update on the management of diabetic retinopathy: Anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy","volume":"13","author":"Bahr","year":"2023","journal-title":"Life"},{"issue":"8","key":"10.1016\/j.exer.2026.111118_bib6","first-page":"1661","article-title":"Systemic effects of intravitreal anti-vegf therapy: a review of safety across organ systems. Ophthalmol","volume":"14","author":"Banerjee","year":"2025","journal-title":"Therapy"},{"issue":"15","key":"10.1016\/j.exer.2026.111118_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.exer.2026.111118_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1139\/Y10-036","article-title":"ET-1 plasma levels and ocular blood flow in retinitis pigmentosa","volume":"88","author":"Cellini","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40659-015-0018-7","article-title":"Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases","volume":"48","author":"Chalghoum","year":"2015","journal-title":"Biol. Res."},{"issue":"20","key":"10.1016\/j.exer.2026.111118_bib10","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.102.20.2479","article-title":"Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine","volume":"102","author":"Chambers","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/cells13030214","article-title":"Moderate elevation of homocysteine induces endothelial dysfunction through adaptive UPR activation and metabolic rewiring","volume":"13","author":"Chatterjee","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nut.2015.08.016","article-title":"High homocysteine, low vitamin B-6, and increased oxidative stress are independently associated with the risk of chronic kidney disease","volume":"32","author":"Chen","year":"2016","journal-title":"Nutrition"},{"issue":"13","key":"10.1016\/j.exer.2026.111118_bib13","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.2009.27.2757","article-title":"Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Choueiri","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archinternmed.2008.574","article-title":"Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's antioxidant and folic acid cardiovascular study","volume":"169","author":"Christen","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.exer.2026.111118_bib15","first-page":"383","article-title":"Homocysteine in the cardiovascular setting: what to know, what to do, and what not to do","volume":"12","author":"D'Elia","year":"2025","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12886-025-04285-4","article-title":"Clinical profile of patients with retinal vein occlusion and its correlation with serum homocysteine levels","volume":"25","author":"Devi","year":"2025","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib17","first-page":"54","article-title":"The effects of vitamin supplementation containing L-methylfolate (Ocufolin forte) on retinal venous pressure and homocysteine plasma levels in patients with glaucoma. Hb TIMES schw","author":"Devogelaere","year":"2021","journal-title":"Aerztej"},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI8342","article-title":"Endothelial dysfunction in a murine model of mild hyperhomocysteinemia","volume":"106","author":"Eberhardt","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2017.07.001","article-title":"Diabetic retinopathy: breaking the barrier","volume":"24","author":"Eshaq","year":"2017","journal-title":"Pathophysiology"},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/ijms20040867","article-title":"The contribution of homocysteine metabolism disruption to endothelial dysfunction: State-Of-The-Art","volume":"20","author":"Esse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.exer.2026.111118_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3126\/nepjoph.v5i2.8728","article-title":"A study on plasma homocysteine level in age-related macular degeneration","volume":"5","author":"Ghosh","year":"2013","journal-title":"Nepal. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3945\/ajcn.112.057091","article-title":"Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration","volume":"98","author":"Gopinath","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12886-023-03149-z","article-title":"Folate and retinal vascular diseases","volume":"23","author":"Gu","year":"2023","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12987-023-00442-3","article-title":"Reduced folate carrier 1 is present in retinal microvessels and crucial for the inner blood-retinal barrier integrity","volume":"20","author":"Gurler","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib26","first-page":"950","article-title":"Cystathionine \u03b2-synthase as novel endogenous regulator of lymphangiogenesis via modulating VEGF receptor 2 and 3. Commun","volume":"5","author":"Hatami","year":"2022","journal-title":"Biol. Met."},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/0019-5154.70667","article-title":"Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in beh\u00e7et's disease","volume":"55","author":"Hodeib","year":"2010","journal-title":"Indian J. Dermatol."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2133\/dmpk.23.285","article-title":"Involvement of reduced folate carrier 1 in the inner blood-retinal barrier transport of methyltetrahydrofolate","volume":"23","author":"Hosoya","year":"2008","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.exer.2026.111118_bib29","article-title":"Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"5","author":"Huang","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/ijms26020746","article-title":"Homocysteine metabolites, endothelial dysfunction, and cardiovascular disease","volume":"26","author":"Jakubowski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111118_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2147\/OPTH.S401743","article-title":"Effects of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on retinal tissue perfusion in mild diabetic retinopathy patients receiving the medical food, ocufolin","volume":"17","author":"Jiang","year":"2023","journal-title":"Clin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.aopr.2025.03.001","article-title":"The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration","volume":"5","author":"Josifova","year":"2025","journal-title":"Adv. Ophthalmol. Pract. Res."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00417-005-0108-2","article-title":"Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration","volume":"244","author":"Kamburoglu","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2026.111118_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252530","article-title":"Significant elevation of aqueous endothelin-1 in central retinal vein occlusion","volume":"16","author":"Kang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2026.111118_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40662-019-0167-9","article-title":"Faulty homocysteine recycling in diabetic retinopathy","volume":"7","author":"Kowluru","year":"2020","journal-title":"Eye Vis. (Lond)."},{"key":"10.1016\/j.exer.2026.111118_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110729","article-title":"Homocysteine and diabetic retinopathy","volume":"262","author":"Lei","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111118_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13098-018-0362-1","article-title":"Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis","volume":"10","author":"Lei","year":"2018","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exer.2026.111118_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104066","article-title":"Improved conjunctival microcirculation in diabetic retinopathy patients with MTHFR polymorphisms after ocufolin administration","volume":"132","author":"Liu","year":"2020","journal-title":"Microvasc. Res."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib39","article-title":"Effects of ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene","volume":"9","author":"Liu","year":"2021","journal-title":"BMJ Open Diabetes Res"},{"key":"10.1016\/j.exer.2026.111118_bib40","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2147\/OPTH.S358753","article-title":"Improved retinal microcirculation in mild diabetic retinopathy patients carrying MTHFR polymorphisms who received the medical food, ocufolin","volume":"16","author":"Liu","year":"2022","journal-title":"Clin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15401-5","article-title":"Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma","volume":"12","author":"Lommatzsch","year":"2022","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.exer.2026.111118_bib42","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3164\/jcbn.17-56","article-title":"Association between vitamin B group supplementation with changes in % flow-mediated dilatation and plasma homocysteine levels: a randomized controlled trial","volume":"64","author":"Maruyama","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib44","doi-asserted-by":"crossref","DOI":"10.61882\/ijotm.2024.15.1182","article-title":"Shehata marker: a promising tool for assessing graft endothelial dysfunction and hypoxic injury","volume":"15","author":"Mohamed","year":"2024","journal-title":"Int. J. Org. Transplant Med."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14744\/ijmb.2025.35682","article-title":"The impact of endothelin-1 on the efficacy of anti-VEGF therapy: a rationale for dual antagonism","volume":"8","author":"Mohamed","year":"2025","journal-title":"Int. J. Med. Biochem."},{"key":"10.1016\/j.exer.2026.111118_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09731-y","article-title":"Hyperhomocysteinemia alters retinal endothelial cells barrier function and angiogenic potential via activation of oxidative stress","volume":"7","author":"Mohamed","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00011-025-02045-0","article-title":"Influence of homocysteine on regulating immunothrombosis: mechanisms and therapeutic potential in management of infections","volume":"74","author":"Nair","year":"2025","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.exer.2026.111118_bib48","article-title":"Bevacizumab increases endothelin-1 production via forkhead box protein O1 in human glomerular microvascular endothelial cells in vitro","volume":"2021","author":"Nihei","year":"2021","journal-title":"Internet J. Nephrol."},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib49","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1152\/japplphysiol.00772.2016","article-title":"Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction","volume":"122","author":"Nishiyama","year":"2017","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000336649","article-title":"Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase","volume":"49","author":"Ohanian","year":"2012","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.exer.2026.111118_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/bs.acc.2015.07.002","article-title":"Homocysteine in chronic kidney disease","volume":"72","author":"Ostrakhovitch","year":"2015","journal-title":"Adv. Clin. Chem."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib52","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170860","article-title":"Homocysteine inhibits angiogenesis through cytoskeleton remodeling","volume":"37","author":"Pan","year":"2017","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib53","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1160\/TH04-05-0284","article-title":"The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction","volume":"92","author":"Peeters","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib54","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1111\/aos.13343","article-title":"Homocysteine and risk of age-related macular degeneration: a systematic review and meta-analysis","volume":"96","author":"Pinna","year":"2018","journal-title":"Acta Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2026.111118_bib55","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3390\/nu13124562","article-title":"Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks","volume":"13","author":"Raghubeer","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.exer.2026.111118_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4940825","article-title":"Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies","volume":"2019","author":"Rodr\u00edguez","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"15","key":"10.1016\/j.exer.2026.111118_bib57","doi-asserted-by":"crossref","first-page":"14844","DOI":"10.1074\/jbc.M312948200","article-title":"Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4","volume":"279","author":"Roybal","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2026.111118_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105115","article-title":"Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy","volume":"161","author":"Rudraraju","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib59","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1096\/fj.15-278648","article-title":"Cystathionine \u03b2-synthase regulates endothelial function via protein S-sulfhydration","volume":"30","author":"Saha","year":"2016","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.exer.2026.111118_bib60","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.3390\/ijms22179356","article-title":"Implication of N-methyl-D-aspartate receptor in homocysteine-induced age-related macular degeneration","volume":"22","author":"Samra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111118_bib61","first-page":"326","article-title":"A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes","volume":"26","author":"Schmidl","year":"2020","journal-title":"Mol. Vis."},{"issue":"24","key":"10.1016\/j.exer.2026.111118_bib62","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.exer.2026.111118_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000090947","article-title":"Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells","volume":"43","author":"Sethi","year":"2006","journal-title":"J. Vasc. Res."},{"issue":"11","key":"10.1016\/j.exer.2026.111118_bib64","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s13300-025-01791-y","article-title":"Evidence-based guidelines for intravitreal anti-VEGF therapy for diabetic retinopathy in chronic kidney disease","volume":"16","author":"Sharma","year":"2025","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.exer.2026.111118_bib66","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/medicina60101647","article-title":"Age-related macular degeneration (AMD): pathophysiology, drug targeting approaches, and recent developments in nanotherapeutics","volume":"60","author":"Singh","year":"2024","journal-title":"Medicina (Coimbra)"},{"key":"10.1016\/j.exer.2026.111118_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mehy.2017.06.012","article-title":"Hyperhomocysteinemia and age-related macular degeneration: role of inflammatory mediators and pyroptosis; a proposal","volume":"105","author":"Singh","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"7","key":"10.1016\/j.exer.2026.111118_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270232","article-title":"A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor","volume":"17","author":"Sj\u00f6bom","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00109-020-02000-y","article-title":"N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction","volume":"99","author":"Tawfik","year":"2021","journal-title":"J. Mol. Med."},{"issue":"8","key":"10.1016\/j.exer.2026.111118_bib68","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/biom10081119","article-title":"Implication of hyperhomocysteinemia in blood retinal barrier (BRB) dysfunction","volume":"10","author":"Tawfik","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.exer.2026.111118_bib70","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/07315724.2008.10719714","article-title":"Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1: evidence for an association of fasting total homocysteine with plasma endothelin-1 levels","volume":"27","author":"Tousoulis","year":"2008","journal-title":"J. Am. Coll. Nutr."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib71","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/HJH.0b013e32833778b2","article-title":"The activation of endothelin-1 pathway during methionine-induced homocysteinemia mediates endothelial dysfunction in hypertensive individuals","volume":"28","author":"Tousoulis","year":"2010","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.exer.2026.111118_bib72","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.exer.2026.111118_bib75","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/diagnostics11040640","article-title":"Nephrotoxicity of anti-angiogenic therapies","volume":"11","author":"Van Wynsberghe","year":"2021","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.exer.2026.111118_bib73","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.ophtha.2005.07.004","article-title":"Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration","volume":"112","author":"Vine","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111118_bib74","first-page":"CD007419","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis","volume":"6","author":"Virgili","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.exer.2026.111118_bib76","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10020-018-0010-0","article-title":"Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine","volume":"24","author":"Xie","year":"2018","journal-title":"Mol. Med."},{"issue":"11","key":"10.1016\/j.exer.2026.111118_bib77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1440-1681.2010.05438.x","article-title":"Homocysteine impaired endothelial function through compromised vascular endothelial growth Factor\/akt\/Endothelial nitric oxide synthase signalling","volume":"37","author":"Yan","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5","key":"10.1016\/j.exer.2026.111118_bib78","first-page":"3913","article-title":"Homocysteine inhibits the viability and migration ability of human umbilical vein endothelial cells by downregulating the expression of vascular endothelial growth factor","volume":"18","author":"Yu","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.exer.2026.111118_bib79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaophthalmol.2023.2098","article-title":"Systemic adverse events among patients with diabetes treated with intravitreal anti-vascular endothelial growth factor injections","volume":"141","author":"Zafar","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2026.111118_bib80","first-page":"7","article-title":"Homocysteine-impaired angiogenesis is associated with VEGF\/VEGFR inhibition","volume":"4","author":"Zhang","year":"2012","journal-title":"Front. Biosci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:38:12Z","timestamp":1784295492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"alternative-id":["S0014483526002745"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111118","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma homocysteine and Endothelin-1 dysregulation: Insights into retinal endothelial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111118"}}